Literature DB >> 11570556

Immune-mediated parasite clearance in mice infected with Plasmodium berghei following treatment with manzamine A.

K K Ang1, M J Holmes, U A Kara.   

Abstract

Manzamine A, a sponge-derived alkaloid, was recently shown to possess in vivo antimalarial activity against the blood stages of the rodent malaria parasite Plasmodium berghei. A single intraperitoneal dose of 100 micromol/kg of manzamine A suppressed parasite growth but was followed by parasite recrudescence. Forty percent of mice with recrudescing parasites were able to recover and clear the fulminating parasitaemia. Examination of sera from these mice revealed that infected mice treated with manzamine A had a suppressed IFN-gamma production but an increase in their IL-10 and IgG production. The prolonged survival of infected mice treated with manzamine A and the eventual clearance of recrudescing parasites in some of these mice involve a down-regulation of Thl responses and a switch to antibody dependent-Th2 responses.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11570556     DOI: 10.1007/s004360000366

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  12 in total

1.  A novel activity from an old compound: Manzamine A reduces the metastatic potential of AsPC-1 pancreatic cancer cells and sensitizes them to TRAIL-induced apoptosis.

Authors:  Esther A Guzmán; Jacob D Johnson; Patricia A Linley; Sarath E Gunasekera; Amy E Wright
Journal:  Invest New Drugs       Date:  2010-03-30       Impact factor: 3.850

2.  Antiplasmodial activity of two medicinal plants against clinical isolates of Plasmodium falciparum and Plasmodium berghei infected mice.

Authors:  Serge David Dago Attemene; Sylvain Beourou; Karim Tuo; Albert Alloh Gnondjui; Abibatou Konate; Andre Offianan Toure; Seraphin Kati-Coulibaly; Joseph Alico Djaman
Journal:  J Parasit Dis       Date:  2017-11-10

3.  Curcumin-arteether combination therapy of Plasmodium berghei-infected mice prevents recrudescence through immunomodulation.

Authors:  Palakkod G Vathsala; Chaitanya Dende; Viswanathan Arun Nagaraj; Debapriya Bhattacharya; Gobardhan Das; Pundi N Rangarajan; Govindarajan Padmanaban
Journal:  PLoS One       Date:  2012-01-20       Impact factor: 3.240

4.  Differential modulation of microglia superoxide anion and thromboxane B2 generation by the marine manzamines.

Authors:  Alejandro M S Mayer; Mary L Hall; Sean M Lynch; Sarath P Gunasekera; Susan H Sennett; Shirley A Pomponi
Journal:  BMC Pharmacol       Date:  2005-03-11

Review 5.  Marine Sponges as a Drug Treasure.

Authors:  Komal Anjum; Syed Qamar Abbas; Sayed Asmat Ali Shah; Najeeb Akhter; Sundas Batool; Syed Shams Ul Hassan
Journal:  Biomol Ther (Seoul)       Date:  2016-07-01       Impact factor: 4.634

6.  Assessment of in vivo antimalarial activity of arteether and garlic oil combination therapy.

Authors:  Vathsala Palakkod Govindan; Aditya Nayak Panduranga; P Krishna Murthy
Journal:  Biochem Biophys Rep       Date:  2016-01-24

Review 7.  Marine Natural Products: A Source of Novel Anticancer Drugs.

Authors:  Shaden A M Khalifa; Nizar Elias; Mohamed A Farag; Lei Chen; Aamer Saeed; Mohamed-Elamir F Hegazy; Moustafa S Moustafa; Aida Abd El-Wahed; Saleh M Al-Mousawi; Syed G Musharraf; Fang-Rong Chang; Arihiro Iwasaki; Kiyotake Suenaga; Muaaz Alajlani; Ulf Göransson; Hesham R El-Seedi
Journal:  Mar Drugs       Date:  2019-08-23       Impact factor: 5.118

Review 8.  Marine sponges as pharmacy.

Authors:  Detmer Sipkema; Maurice C R Franssen; Ronald Osinga; Johannes Tramper; René H Wijffels
Journal:  Mar Biotechnol (NY)       Date:  2005-03-24       Impact factor: 3.619

9.  The marine natural product manzamine A targets vacuolar ATPases and inhibits autophagy in pancreatic cancer cells.

Authors:  Georgios Kallifatidis; Dominic Hoepfner; Tiphaine Jaeg; Esther A Guzmán; Amy E Wright
Journal:  Mar Drugs       Date:  2013-09-17       Impact factor: 5.118

Review 10.  Blue-Print Autophagy: Potential for Cancer Treatment.

Authors:  Nadia Ruocco; Susan Costantini; Maria Costantini
Journal:  Mar Drugs       Date:  2016-07-21       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.